EIN 52-1224577

Biotechnology Innovation Organization (BIO)

IRS 501(c) type
501(c)(6)
Num. employees
175
Year formed
1981
Most recent tax filings
2022-12-01
NTEE code, primary
Description
BIO's mission is to advocate for our members, and we also work towards enriching the industry with networking, partnering and education opportunities.
Also known as...
Biotechnology Industry Organization
Total revenues
$103,185,175
2022
Total expenses
$86,344,110
2022
Total assets
$124,412,600
2022
Num. employees
175
2022

Program areas at BIO

Advocacy: Biotechnology Innovation Organization (bio)'s advocacy efforts reflect the priorities identified by the bio board of directors and the four section governing boards.the board of directors focuses on issues of importance to all bio members, regardless of their size or technology. These cross-cutting advocacy accomplishments for the year are listed below: - safeguarded and advanced intellectual property protections, domestically and internationally.- fostered a dialogue about bioethics and proactively advanced the socially responsible use of Biotechnology.- promoted investment in government and academic research.- expanded outreach to foreign governments and international entities to educate on policy issues of importance to the Biotechnology industry and to improve the investment and regulatory climate for biotech products.the health section advocacy accomplishments: - promoted healthcare policies that recognize both the promise and value of Innovation.- advocated for a safe and predictable regulatory environment for value-based payment arrangements for drugs and biologics.- enhanced and protected patient access to innovative therapies and promoted the need for greater nondiscrimination enforcement against insurance benefit designs.- advocated for biosimilars policies that protect patient safety, promote biomedical Innovation, and advance the science-based review and approval of biosimilars and interchangeable biological products.- promoted the value of u.s. government investments in programs that improve access to immunizations and foster vaccine Innovation, strengthened our ability to respond to bioterror threats or emerging infectious diseases, and encouraged development of new products to fight antimicrobial resistance (amr).- influenced improvements to the international environment for biomedical Innovation and global public health preparedness.- advocated for the modernization of the clinical development paradigm.the emerging companies section advocacy accomplishments: - advanced the interest of emerging companies in capital formation and financial services policy.- advocated for fiscal policies supporting innovative emerging companies and investment in groundbreaking r&d; enhanced the voice of pre-revenue, r&d-intensive businesses- advocated for the removal of burdensome financial reporting regulations on emerging companies.the food & agriculture section advocacy accomplishments: - worked with the administration and congress to advance improvements to the u.s. and global regulatory systems for ag-biotech products. - worked with members of the agricultural value chain to address trade issues in agricultural export markets such as china and europe. - advocated in legislatures and courts to preserve the rights of farmers to plant genetically engineered crops. The industrial & environmental section advocacy accomplishments: - supported a renewable chemicals report.- advocated for epa to treat all sustainably sourced biomass as eligible measures for emissions reduction credit (erc) generation. - advocated regarding the implementation of the toxic substances control act (tsca) as amended by congress, as well as issues relating to the national bioengineered food disclosure act.- engaged with the administration's review of the coordinated framework for Biotechnology, including with respect to the regulation of genetically engineered (ge) algae.
Services: bio's services include conferences and activities that bring advocacy accomplishments listed below:- safeguarded and advanced intellectual property protections, domestically and internationally.- fostered a dialogue about bioethics and proactively advanced the socially responsible use of Biotechnology.- promoted investment in government and academic research.- brought together industry stakeholders and investors for events ranging from the bio international convention to conferences for busines development executives.the bio international convention attracts the most influential biotech and pharma attendees from 73 countries and 47 u.s. states, as well as the district of columbia, puerto rico and the us virgin islands and offers professional and business development opportunities. The net income from the convention supports our advocacy, public outreach, and other member service activities.the key elements of the bio international convention are educational programming, exhibition, the bio business forum, and networking events. These elements provide an opportunity for Biotechnology and pharmaceutical companies, academic research institutions, and investors from around the world to learn about recent scientific and policy developments, and schedule one-on-one meetings to discuss potential business opportunities. The bio business forum at the convention hosts tens of thousands of partnering meetings among a few thousand companies, along with a couple hundred company presentations. The convention hosts hundreds of speakers, and over a thousand exhibitions with international, regional and state pavilions (and a number of product focus zones).beyond the convention, bio hosts or co-hosts a number of national and international conferences that provide venues for member and non-member companies to present new data, meet with fellow biotech companies, and attract funding from investors and other organizations.

Grants made by BIO

GranteeGrant descriptionAmount
National Health CouncilSponsorship$70,000
BioNJSponsorship$35,000
American Cancer Society Cancer Action Network (ACSCAN)Sponsorship$25,000
...and 30 more grants made totalling $473,610

Who funds Biotechnology Innovation Organization (BIO)

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
We Work for HealthState-Level Partnership for Support and Expansion of Bio Affiliates$250,000

Personnel at BIO

NameTitleCompensation
Michelle McMurry-HeathPresident and Chief Executive Officer$2,345,095
Stephen JaskoChief Financial Officer and Executive Vice President of Business Development$658,466
Rich MastersChief Public Affairs and Marketing Officer$643,726
John MurphyChief Policy Officer
Nick ShipleyChief Advocacy Officer
...and 18 more key personnel

Financials for BIO

RevenuesFYE 12/2022
Total grants, contributions, etc.$874,632
Program services$77,932,917
Investment income and dividends$1,361,299
Tax-exempt bond proceeds$0
Royalty revenue$20,939,661
Net rental income$0
Net gain from sale of non-inventory assets$2,055,689
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$20,977
Total revenues$103,185,175

Form 990s for BIO

Fiscal year endingDate received by IRSFormPDF link
2022-122023-11-10990View PDF
2021-122022-11-15990View PDF
2020-122021-11-13990View PDF
2019-122021-06-25990View PDF
2018-122020-02-18990View PDF
...and 9 more Form 990s

Organizations like BIO

OrganizationLocationRevenue
Nuclear Energy Institute (NEI)Washington, DC$52,030,460
CompTIADowners Grove, IL$144,834,551
CableLabsLouisville, CO$79,901,749
Cotton IncorporatedCary, NC$83,241,579
American Chemistry Council (ACC)Washington, DC$149,402,320
Million Dollar Round TablePark Ridge, IL$61,600,919
National Association of Home Builders (NAHB)Washington, DC$70,308,249
CSA GroupCanada, $180,418,638
Confederation of Indian Industry (CII)Arlington, VA$45,402,839
Performance Review Institute (PRI)Warrendale, PA$48,567,754
Data update history
January 21, 2024
Posted financials
Added Form 990 for fiscal year 2022
January 21, 2024
Updated personnel
Identified 22 new personnel
January 16, 2024
Updated personnel
Identified 4 new personnel
December 31, 2023
Used new vendors
Identified 8 new vendors, including , , , , , , , and
December 29, 2023
Received grants
Identified 1 new grant, including a grant for $250,000 from We Work for Health
Nonprofit Types
Trade associationsBusiness and community development organizations
Issues
Science and technologyBusiness and industry
Characteristics
MembershipsPolitical advocacyConducts researchOperates internationallyCommunity engagement / volunteering
General information
Address
1201 New York Ave NW No 1300
Washington, DC 20005
Metro area
Washington-Arlington-Alexandria, DC-VA-MD-WV
County
District of Columbia, DC
Website URL
bio.org/ 
Phone
(202) 962-9200
Facebook page
IAmBiotech 
Twitter profile
@iambiotech 
IRS details
EIN
52-1224577
Fiscal year end
December
Taxreturn type
Form 990
Year formed
1981
Eligible to receive tax-deductible contributions (Pub 78)
No
Categorization
NTEE code, primary
S40: Business and Industry
NAICS code, primary
813910: Trade Associations
Parent/child status
Independent
Free account sign-up

Want updates when BIO has new information, or want to find more organizations like Biotechnology Innovation Organization (BIO)?

Create free Cause IQ account